DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy

Photo: HealthVetted editorial render
GLP-1 receptor agonist

Photo: HealthVetted editorial render
GLP-1 receptor agonist
| # | Product | Active ingredient | Starting price | FDA status | Score | |
|---|---|---|---|---|---|---|
| 1 | Talkspace | — | Best ·— | service | Top ·8.0 | See offer → |
| 2 | BetterHelp | — | $260/mo | service | 7.9 | See offer → |
Talkspace is a telehealth platform, not a drug. After a short intake (handled by a bot or matching agent), it pairs you with a licensed therapist (psychologist, LCSW, LMFT, or licensed counselor) based on your stated concerns, location, and preferences. You communicate through a private digital "room" using text, audio, and video messages, with options for scheduled live 30-minute sessions (video, audio, or chat) depending on your plan. A separate Talkspace Psychiatry service connects adults to prescribers who can evaluate you over video and prescribe and manage non-controlled medications (such as antidepressants) sent to your local pharmacy. Care is asynchronous plus synchronous, meaning you can message any time and your therapist typically responds during their working hours, about five days a week.
BetterHelp is a digital platform, not a treatment itself. You complete an intake questionnaire, and an algorithm plus human review matches you with a licensed therapist (LCSW, LPC, LMFT, or psychologist), usually within a day or two. You then receive talk therapy through a weekly live session of roughly 30-45 minutes by video, phone, or live chat, plus the ability to message your therapist between sessions. The therapeutic work itself is standard psychotherapy (such as CBT-style approaches), just delivered remotely; you can switch therapists at any time at no extra cost if the fit isn't right.
Talkspace is among the better-studied online therapy platforms, though most of the published evidence comes from observational studies of its own users rather than randomized controlled trials. A study of 10,718 platform users published in BMC Psychiatry (2020) found that roughly 53% of users reduced PHQ-9 depression scores by 5 or more points and about 48% reduced GAD-7 anxiety scores by 5 or more points by their final assessment, with improvement rates the authors described as consistent with face-to-face therapy. A separate naturalistic study of 5,890 clients published in JMIR Formative Research (2022) reported the average client's PHQ-8 depression score improved from 15 to below the clinical cutoff of 10 by week 6, although about 37% of clients had disengaged from therapy by that point. Because these are real-world rather than placebo-controlled outcomes, the results reflect motivated users who stayed engaged and may overstate what a typical or less-engaged user experiences.
A peer-reviewed naturalistic study of 318 BetterHelp users, published in JMIR mHealth and uHealth (2019), found depression symptom severity fell significantly over three months: mean PHQ-9 scores dropped from 12.57 (moderate) to 9.36 (mild), a statistically significant change (p < .001) with a medium effect size (Cohen's d = 0.61). About 37.8% showed clinically significant improvement and 19.8% reached remission. Important limitations: the study had no control group (so it cannot prove BetterHelp caused the improvement), and two of its authors disclosed ties to BetterHelp (a former consultant and a company employee), which is a conflict of interest to keep in mind. Separately, BetterHelp's own 2024 platform-outcomes white paper reports that 72% of clients experienced symptom reduction within 12 weeks, but as company-published, non-peer-reviewed data, that figure should be treated with caution. More broadly, multiple meta-analyses find remote (tele)therapy is generally comparable to in-person care for common conditions like anxiety and depression, though a few studies note a modest in-person advantage for depression.
Therapy itself has no physical side effects, though briefly feeling worse, emotionally raw, or fatigued after discussing difficult topics is normal. The most common practical drawbacks reported are slow or limited therapist responses on messaging-only plans and occasional therapist mismatches. If you use Talkspace Psychiatry, any prescribed medication carries its own side effects (for example, antidepressants can cause nausea, sleep changes, or sexual dysfunction, and some carry an FDA boxed warning about increased suicidal thoughts in people under 25) that you should discuss with the prescriber. The platform's key limitation is that it is not designed for acute crises and does not provide 24/7 emergency intervention.
Talk therapy is generally low-risk, but it is not side-effect-free: discussing painful topics can temporarily increase distress, anxiety, or emotional fatigue, and progress can feel slow or stall. Platform-specific drawbacks include inconsistent therapist quality, occasional matching mismatches that require a switch, and limited usefulness in emergencies, since BetterHelp is not a crisis service. The most serious historical concern is privacy: in 2023 the FTC charged BetterHelp with sharing sensitive user data (including health-questionnaire responses, email addresses, and IP data) with advertisers such as Facebook, Snapchat, Criteo, and Pinterest, despite promising to keep that data private. BetterHelp agreed to pay $7.8 million (used for partial consumer refunds) and is now barred from sharing such data for advertising.
As of 2026, out-of-pocket Talkspace therapy runs about $69/week ($276/month) for messaging-only, $99/week ($396/month) for messaging plus a weekly live session, and $109/week ($436/month) for messaging, live sessions, and workshops; extra live sessions are about $65 each. Psychiatry is roughly $299 for the initial evaluation, with lower-cost follow-up visits (around $175) and bundle options. The bigger story is insurance: Talkspace is in-network with many major plans (including Aetna, Cigna, Optum, Anthem and Blue Cross Blue Shield, plus Medicare and TRICARE) and through many employers and EAPs, where the company reports an average copay around $10 and that many members pay $0. Always verify your specific coverage first, since with insurance the effective cost can be a fraction of the sticker price. HSA and FSA funds are generally accepted.
As of 2026, BetterHelp typically costs about $70-$100 per week, which works out to roughly $280-$400 per month; exact pricing varies by location and therapist availability, and the company has been rolling out weekly billing across most of the US. Need-based financial aid can reduce the rate for those who qualify. Historically BetterHelp did not accept insurance, but as of early 2026 it has begun adding coverage through select insurers (such as Cigna, UnitedHealthcare, Aetna, and Optum) in a limited number of states. With strong insurance, traditional in-network therapy (often a $15-$40 copay per visit) can be cheaper; without insurance, BetterHelp's flat rate may undercut typical $100-$200 self-pay session fees.
Talkspace serves U.S. adults seeking therapy for mild-to-moderate concerns such as depression, anxiety, stress, relationship issues, and life transitions, and offers couples therapy and a Teens program for ages 13 to 17 (with parental or guardian consent, with limited legal exceptions). Psychiatry and medication management are limited to adults 18 and older. It is NOT appropriate for psychiatric emergencies, active suicidal or homicidal thoughts, self-harm, or severe, acute conditions such as psychosis or active substance-use crises; in those cases call or text 988 (Suicide and Crisis Lifeline), text START to 741741, or call 911. Talkspace also cannot prescribe controlled substances (for example Adderall, Xanax, Klonopin, Ritalin, Vyvanse, or Valium), so people who specifically need stimulants or benzodiazepines should seek care from a provider who can prescribe them.
Best for adults with mild-to-moderate anxiety, depression, stress, relationship issues, grief, or life transitions, and for people facing practical barriers to in-person care (rural location, mobility limits, tight schedules). It is NOT appropriate for psychiatric emergencies, active suicidal thoughts, psychosis, severe eating disorders, or substance-use crises. BetterHelp therapists do not prescribe medication, do not provide formal diagnoses for legal or disability purposes, and do not fulfill court-ordered therapy. Anyone in crisis should call or text 988 (Suicide and Crisis Lifeline) or call 911. People who need medication management require a separate prescriber or psychiatry service.
BetterHelp: BetterHelp is a subscription online-therapy platform that pairs you with a licensed therapist for weekly video, phone, or chat sessions plus between-session messaging, costing roughly $280-$400 per month as of 2026. Peer-reviewed data suggest meaningful relief of depression symptoms, but it offers no medication, isn't built for severe illness or crises, and carries a notable privacy history including a 2023 FTC settlement. Both are strong options — match the pick to your specific needs, budget, and clinician's guidance.
Editorial comparison, not medical advice. Discuss options with a qualified clinician. Individual results vary.